NAS:ONCE (USA) Also Trade In: Germany UK

Spark Therapeutics Inc $ 113.57 0 (0%)

Volume:
0
Avg Vol (1m):
0
Market Cap $:
4.38 Bil
Enterprise Value $:
4.38 Bil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected with ONCE. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Spark Therapeutics Inc () from 2015 to Oct 25 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Spark Therapeutics stock (ONCE) PE ratio as of Oct 25 2020 is 0. More Details

Spark Therapeutics PE Ratio (TTM) Chart

EMBED

Spark Therapeutics PE Ratio (TTM) Historical Data

Total 1034
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Spark Therapeutics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-10-260.0 2019-10-170.0
2019-12-180.0 2019-10-160.0
2019-12-170.0 2019-10-150.0
2019-12-160.0 2019-10-140.0
2019-12-130.0 2019-10-110.0
2019-12-120.0 2019-10-100.0
2019-12-110.0 2019-10-090.0
2019-12-100.0 2019-10-080.0
2019-12-090.0 2019-10-070.0
2019-12-060.0 2019-10-040.0
2019-12-050.0 2019-10-030.0
2019-12-040.0 2019-10-020.0
2019-12-030.0 2019-10-010.0
2019-12-020.0 2019-09-300.0
2019-11-290.0 2019-09-270.0
2019-11-280.0 2019-09-260.0
2019-11-270.0 2019-09-250.0
2019-11-260.0 2019-09-240.0
2019-11-250.0 2019-09-230.0
2019-11-220.0 2019-09-200.0
2019-11-210.0 2019-09-190.0
2019-11-200.0 2019-09-180.0
2019-11-190.0 2019-09-170.0
2019-11-180.0 2019-09-160.0
2019-11-150.0 2019-09-130.0
2019-11-140.0 2019-09-120.0
2019-11-130.0 2019-09-110.0
2019-11-120.0 2019-09-100.0
2019-11-110.0 2019-09-090.0
2019-11-080.0 2019-09-060.0
2019-11-070.0 2019-09-050.0
2019-11-060.0 2019-09-040.0
2019-11-050.0 2019-09-030.0
2019-11-040.0 2019-09-020.0
2019-11-010.0 2019-08-300.0
2019-10-310.0 2019-08-290.0
2019-10-300.0 2019-08-280.0
2019-10-290.0 2019-08-270.0
2019-10-280.0 2019-08-260.0
2019-10-250.0 2019-08-230.0
2019-10-240.0 2019-08-220.0
2019-10-230.0 2019-08-210.0
2019-10-220.0 2019-08-200.0
2019-10-210.0 2019-08-190.0
2019-10-180.0 2019-08-160.0

Spark Therapeutics PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325414 NAICS : 2836
Traded in other countries 272.Germany 0L8L.UK ONCE.USA
Address 3737 Market Street, Suite 1300, Philadelphia, PA, USA, 19104
Spark Therapeutics Inc is a biotechnology company with a focus on gene therapy and orphan disease treatment. The company has one business segment, Pharmaceuticals, which is principally engaged in utilizing gene therapy to develop products to aid patients suffering from debilitating diseases. Spark has a pipeline with products that target choroideremia, genetic blinding conditions or inherited retinal disease, and a product targeting hematologic disorders. The company earns the vast majority of its revenue in the United States.